Anti-inflammatory effect of transforming growth factor-β1 in myoblast transplantation

Transplantation

Volumn 65, Issue 6, 1998, Pages 793-799

  Merly, Franck ^a   Huard, Christine ^a   Asselin, Isabelle ^a   Robbins, Paul D ^b   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VECTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; GENETIC TRANSDUCTION; MUSCLE DISEASE; MUSCULAR DYSTROPHY; MYOBLAST; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MICE; MUSCLE, SKELETAL; MUSCLES; NEUTROPHILS; PEROXIDASE; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032571370     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803270-00005     Document Type: Article

References (37)

1. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337: 176.
2. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immuno-suppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993; 2: 99.
3. Tremblay JP, Bouchard JP, Malouin F, et al. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul Disord 1993; 3: 583.
4. Kinoshita I, Vilquin JT, Guérette B, Asselin I, Roy R, Tremblay JP. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994; 17: 1407.
5. Kinoshita I, Huard J, Tremblay JP. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve 1994; 17: 975.
6. Vilquin JT, Wagner E, Kinoshita I, Roy R, Tremblay JP. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 1995; 131: 975.
7. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994; 93: 586.
8. Huard J, Acsadi G, Jani A, Massie B, Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994; 5: 949.
9. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Quantitative study of efficacy of myoblast transplantation. Muscle Nerve 1994; 4: S261.
10. Fan Y, Maley M, Beilharz M, Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996; 19: 853.
11. Guérette B, Skuk D, Celestin F, et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 1997; 159 .
12. Kinoshita I, Vilquin JT, Gravel C, Roy R, Tremblay JP. Myoblast allotransplantation in primates. Muscle Nerve 1995; 18: 1217.
13. Kinoshita I, Roy R, Dugré FJ, et al. Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol 1996; 55(6): 687.
14. Gussoni E, Pavlath GK, Lanctot AM, et al. Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 1992; 356: 435.
15. Huard J, Bouchard JP, Roy R, et al. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992; 15: 550.
16. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995; 333: 832.
17. Michealis D, Goebels M, Mohifeld R. Constitutive and cytokine-induced expression of human leucocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 1993; 143: 1142.
18. Sporn MB, Roberts AB. Transforming growth factor-beta: multiple actions and potential clinical applications. JAMA 1989; 262: 938.
19. Wahl SM, Allen JB, Wong HL, Dougherty SF, Ellingsworth LR. Antagonistic and agonistic effects of transforming growth factor-β and IL-1 in rheumatoid synovium. J Immunol 1990; 145: 2514.
20. Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP. Transforming growth factor β exerts opposite effects from interleukin-1beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1993; 36: 44.
21. Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 1993; 150: 3553.
22. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M. Induction of the interleukin-1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 1991; 21: 1635.
23. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR. Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 1996; 157: 360.
24. Nelson BJ, Ralph P, Green SJ, Nacy CA. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J Immunol 1991; 146: 1849.
25. Malygin AM, Meri S, Timonen T. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2. Scand J Immunol 1993; 37: 71.
26. Balazovich KJ, Fernandez R, Hinkovska-Galcheva V, Suchard SJ, Boxer LA. Transforming growth factor-β1 stimulates degranulation and oxidant release by adherent human neutrophils. J Leukoc Biol 1996; 60: 772.
27. Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med 1990; 172: 1777.
28. Qin L, Chavin KD, Ding Y, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 1995; 59: 809.
29. Qin L, Ding Y, Bromberg JS. Gene transfer of transforming growth factor-β1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 1996; 7: 1981.
30. Gill RG. Transforming growth factor beta prevents islet allograft rejection. Transplant Proc 1991; 23: 747.
31. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206.
32. Raz E, Watanabe A, Baird SM, et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993; 90: 4523.
33. Lioté F, Prudhommeaux F, Schiltz C, et al. Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by tranforming growth factor β1. Arthritis Rheum 1996; 39(7): 1192.
34. Lefer AM, Tsao P, Aoki N, Palladino MA. Mediation of cardioprotection by transforming growth factor-β. Science 1990; 249: 61.
35. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334: 260.
36. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leukoc Biol 1995; 58: 690.
37. Berton G, Laudanna C, Sorio C, Rossi F. Generation of signals activating neutrophil functions by leukocyte integrins: LFA1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. J Cell Biol 1992; 116: 1007.